Replies to post #247816 on Avid Bioservices Inc (CDMO)

[corporalagarn]

I agree with you, but the market won't. It never does. Ten years and counting for me. Doubled my position over the past six months. Hopefully 2016 will be PPHM's year. Tenth year in a row I've heard that.

[InternetForumUser]

With all of the past stellar clinical trial data why would there be a need to build up scientific credibility? Isn't PS a cornerstone molecule that everyone is aware of? How about the P3 data being better than what was PR'd because management was sandbagging?

Is it scientific credibility or a lack of Peregrine Management Credibility?

[ArchieK]

Smart and important people, labs, companies...have more opportunity to engage in things than they have capacity. So when a top notch person, lab, company takes you in to their portfolio it's after some level of due diligence and a feeling that THEY could benefit from the association as well. $2mil is not a lot of money in the sphere of spending that is represented by that collaboration. I think it is simply the admission price, nothing more or less. I'd rather see them spend $2mil on THAT than ads, PR, IR etc. There will be hay made from this investment in the form of credibility, exposure, and data. IMHO.